Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Jun;62(6):1320–1331. doi: 10.1086/301874

X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.

J Rae 1, P E Newburger 1, M C Dinauer 1, D Noack 1, P J Hopkins 1, R Kuruto 1, J T Curnutte 1
PMCID: PMC1377153  PMID: 9585602

Abstract

Chronic granulomatous disease (CGD) is a hereditary disorder of host defense due to absent or decreased activity of phagocyte NADPH oxidase. The X-linked form of the disease derives from defects in the CYBB gene, which encodes the 91-kD glycoprotein component (termed "gp91-phox") of the oxidase. We have identified the mutations in the CYBB gene responsible for X-linked CGD in 131 consecutive independent kindreds. Screening by SSCP analysis identified mutations in 124 of the kindreds, and sequencing of all exons and intron boundary regions revealed the other seven mutations. We detected 103 different specific mutations; no single mutation appeared in more than seven independent kindreds. The types of mutations included large and small deletions (11%), frameshifts (24%), nonsense mutations (23%), missense mutations (23%), splice-region mutations (17%), and regulatory-region mutations (2%). The distribution of mutations within the CYBB gene exhibited great heterogeneity, with no apparent mutational hot spots. Evaluation of 87 available mothers revealed X-linked carrier status in all but 10. The heterogeneity of mutations and the lack of any predominant genotype indicate that the disease represents many different mutational events, without a founder effect, as is expected for a disorder with a previously lethal phenotype.

Full Text

The Full Text of this article is available as a PDF (758.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariga T., Sakiyama Y., Furuta H., Matsumoto S. Molecular genetic studies of two families with X-linked chronic granulomatous disease: mutation analysis and definitive determination of carrier status in patients' sisters. Eur J Haematol. 1994 Feb;52(2):99–102. doi: 10.1111/j.1600-0609.1994.tb01293.x. [DOI] [PubMed] [Google Scholar]
  2. Ariga T., Sakiyama Y., Matsumoto S. Two novel point mutations in the cytochrome b 558 heavy chain gene, detected in two Japanese patients with X-linked chronic granulomatous disease. Hum Genet. 1994 Oct;94(4):441–441. doi: 10.1007/BF00201609. [DOI] [PubMed] [Google Scholar]
  3. Azuma H., Oomi H., Sasaki K., Kawabata I., Sakaino T., Koyano S., Suzutani T., Nunoi H., Okuno A. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Blood. 1995 Jun 1;85(11):3274–3277. [PubMed] [Google Scholar]
  4. BERENDES H., BRIDGES R. A., GOOD R. A. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–312. [PubMed] [Google Scholar]
  5. BRIDGES R. A., BERENDES H., GOOD R. A. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child. 1959 Apr;97(4):387–408. [PubMed] [Google Scholar]
  6. Baehner R. L., Kunkel L. M., Monaco A. P., Haines J. L., Conneally P. M., Palmer C., Heerema N., Orkin S. H. DNA linkage analysis of X chromosome-linked chronic granulomatous disease. Proc Natl Acad Sci U S A. 1986 May;83(10):3398–3401. doi: 10.1073/pnas.83.10.3398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bolscher B. G., de Boer M., de Klein A., Weening R. S., Roos D. Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood. 1991 Jun 1;77(11):2482–2487. [PubMed] [Google Scholar]
  8. Bu-Ghanim H. N., Segal A. W., Keep N. H., Casimir C. M. Molecular analysis in three cases of X91- variant chronic granulomatous disease. Blood. 1995 Nov 1;86(9):3575–3582. [PubMed] [Google Scholar]
  9. Burritt J. B., Quinn M. T., Jutila M. A., Bond C. W., Jesaitis A. J. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem. 1995 Jul 14;270(28):16974–16980. doi: 10.1074/jbc.270.28.16974. [DOI] [PubMed] [Google Scholar]
  10. Carothers A. M., Urlaub G., Grunberger D., Chasin L. A. Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol. 1993 Aug;13(8):5085–5098. doi: 10.1128/mcb.13.8.5085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Casimir C. M., Bu-Ghanim H. N., Rodaway A. R., Bentley D. L., Rowe P., Segal A. W. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2753–2757. doi: 10.1073/pnas.88.7.2753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cross A. R., Rae J., Curnutte J. T. Cytochrome b-245 of the neutrophil superoxide-generating system contains two nonidentical hemes. Potentiometric studies of a mutant form of gp91phox. J Biol Chem. 1995 Jul 21;270(29):17075–17077. doi: 10.1074/jbc.270.29.17075. [DOI] [PubMed] [Google Scholar]
  13. Curnutte J. T. Classification of chronic granulomatous disease. Hematol Oncol Clin North Am. 1988 Jun;2(2):241–252. [PubMed] [Google Scholar]
  14. Curnutte J. T., Kuver R., Scott P. J. Activation of neutrophil NADPH oxidase in a cell-free system. Partial purification of components and characterization of the activation process. J Biol Chem. 1987 Apr 25;262(12):5563–5569. [PubMed] [Google Scholar]
  15. DeLeo F. R., Quinn M. T. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol. 1996 Dec;60(6):677–691. doi: 10.1002/jlb.60.6.677. [DOI] [PubMed] [Google Scholar]
  16. Densen P., Wilkinson-Kroovand S., Mandell G. L., Sullivan G., Oyen R., Marsh W. L. Kx: its relationship to chronic granulomatous disease and genetic linkage with Xg. Blood. 1981 Jul;58(1):34–37. [PubMed] [Google Scholar]
  17. Dinauer M. C., Curnutte J. T., Rosen H., Orkin S. H. A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease. J Clin Invest. 1989 Dec;84(6):2012–2016. doi: 10.1172/JCI114393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dinauer M. C., Pierce E. A., Bruns G. A., Curnutte J. T., Orkin S. H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990 Nov;86(5):1729–1737. doi: 10.1172/JCI114898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Eklund E. A., Skalnik D. G. Characterization of a gp91-phox promoter element that is required for interferon gamma-induced transcription. J Biol Chem. 1995 Apr 7;270(14):8267–8273. doi: 10.1074/jbc.270.14.8267. [DOI] [PubMed] [Google Scholar]
  20. Ezekowitz R. A., Dinauer M. C., Jaffe H. S., Orkin S. H., Newburger P. E. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med. 1988 Jul 21;319(3):146–151. doi: 10.1056/NEJM198807213190305. [DOI] [PubMed] [Google Scholar]
  21. Ezekowitz R. A., Orkin S. H., Newburger P. E. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest. 1987 Oct;80(4):1009–1016. doi: 10.1172/JCI113153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Finn A., Hadzić N., Morgan G., Strobel S., Levinsky R. J. Prognosis of chronic granulomatous disease. Arch Dis Child. 1990 Sep;65(9):942–945. doi: 10.1136/adc.65.9.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Forrest C. B., Forehand J. R., Axtell R. A., Roberts R. L., Johnston R. B., Jr Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am. 1988 Jun;2(2):253–266. [PubMed] [Google Scholar]
  24. Frey D., Mächler M., Seger R., Schmid W., Orkin S. H. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. Blood. 1988 Jan;71(1):252–255. [PubMed] [Google Scholar]
  25. Ginsburg D., Handin R. I., Bonthron D. T., Donlon T. A., Bruns G. A., Latt S. A., Orkin S. H. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science. 1985 Jun 21;228(4706):1401–1406. doi: 10.1126/science.3874428. [DOI] [PubMed] [Google Scholar]
  26. Holmes B., Quie P. G., Windhorst D. B., Good R. A. Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet. 1966 Jun 4;1(7449):1225–1228. doi: 10.1016/s0140-6736(66)90238-8. [DOI] [PubMed] [Google Scholar]
  27. Imajoh-Ohmi S., Tokita K., Ochiai H., Nakamura M., Kanegasaki S. Topology of cytochrome b558 in neutrophil membrane analyzed by anti-peptide antibodies and proteolysis. J Biol Chem. 1992 Jan 5;267(1):180–184. [PubMed] [Google Scholar]
  28. Iwata M., Nunoi H., Yamazaki H., Nakano T., Niwa H., Tsuruta S., Ohga S., Ohmi S., Kanegasaki S., Matsuda I. Homologous dinucleotide (GT or TG) deletion in Japanese patients with chronic granulomatous disease with p47-phox deficiency. Biochem Biophys Res Commun. 1994 Mar 30;199(3):1372–1377. doi: 10.1006/bbrc.1994.1382. [DOI] [PubMed] [Google Scholar]
  29. Kessler O., Chasin L. A. Effects of nonsense mutations on nuclear and cytoplasmic adenine phosphoribosyltransferase RNA. Mol Cell Biol. 1996 Aug;16(8):4426–4435. doi: 10.1128/mcb.16.8.4426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kuribayashi F., de Boer M., Leusen J. H., Verhoeven A. J., Roos D. A novel polymorphism in the coding region of CYBB, the human gp91-phox gene. Hum Genet. 1996 May;97(5):611–613. doi: 10.1007/BF02281870. [DOI] [PubMed] [Google Scholar]
  31. Lange K., Gladstien K., Zatz M. Effects of reproductive compensation and genetic drift on X-linked lethals. Am J Hum Genet. 1978 Mar;30(2):180–189. [PMC free article] [PubMed] [Google Scholar]
  32. Leto T. L., Lomax K. J., Volpp B. D., Nunoi H., Sechler J. M., Nauseef W. M., Clark R. A., Gallin J. I., Malech H. L. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science. 1990 May 11;248(4956):727–730. doi: 10.1126/science.1692159. [DOI] [PubMed] [Google Scholar]
  33. Leusen J. H., Verhoeven A. J., Roos D. Interactions between the components of the human NADPH oxidase: intrigues in the phox family. J Lab Clin Med. 1996 Nov;128(5):461–476. doi: 10.1016/s0022-2143(96)90043-8. [DOI] [PubMed] [Google Scholar]
  34. Leusen J. H., de Boer M., Bolscher B. G., Hilarius P. M., Weening R. S., Ochs H. D., Roos D., Verhoeven A. J. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest. 1994 May;93(5):2120–2126. doi: 10.1172/JCI117207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Maquat L. E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA. 1995 Jul;1(5):453–465. [PMC free article] [PubMed] [Google Scholar]
  36. Mouy R., Fischer A., Vilmer E., Seger R., Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989 Apr;114(4 Pt 1):555–560. doi: 10.1016/s0022-3476(89)80693-6. [DOI] [PubMed] [Google Scholar]
  37. Nagaraja R., MacMillan S., Kere J., Jones C., Griffin S., Schmatz M., Terrell J., Shomaker M., Jermak C., Hott C. X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res. 1997 Mar;7(3):210–222. doi: 10.1101/gr.7.3.210. [DOI] [PubMed] [Google Scholar]
  38. Newburger P. E., Malawista S. E., Dinauer M. C., Gelbart T., Woodman R. C., Chada S., Shen Q., van Blaricom G., Quie P. G., Curnutte J. T. Chronic granulomatous disease and glutathione peroxidase deficiency, revisited. Blood. 1994 Dec 1;84(11):3861–3869. [PubMed] [Google Scholar]
  39. Newburger P. E., Skalnik D. G., Hopkins P. J., Eklund E. A., Curnutte J. T. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558. J Clin Invest. 1994 Sep;94(3):1205–1211. doi: 10.1172/JCI117437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Nunoi H., Rotrosen D., Gallin J. I., Malech H. L. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science. 1988 Dec 2;242(4883):1298–1301. doi: 10.1126/science.2848319. [DOI] [PubMed] [Google Scholar]
  41. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766–2770. doi: 10.1073/pnas.86.8.2766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  43. Parkos C. A., Dinauer M. C., Walker L. E., Allen R. A., Jesaitis A. J., Orkin S. H. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. Proc Natl Acad Sci U S A. 1988 May;85(10):3319–3323. doi: 10.1073/pnas.85.10.3319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Rabbani H., de Boer M., Ahlin A., Sundin U., Elinder G., Hammarström L., Palmblad J., Smith C. I., Roos D. A 40-base-pair duplication in the gp91-phox gene leading to X-linked chronic granulomatous disease. Eur J Haematol. 1993 Oct;51(4):218–222. doi: 10.1111/j.1600-0609.1993.tb00634.x. [DOI] [PubMed] [Google Scholar]
  45. Redman C. M., Marsh W. L. The Kell blood group system and the McLeod phenotype. Semin Hematol. 1993 Jul;30(3):209–218. [PubMed] [Google Scholar]
  46. Reed R., Maniatis T. A role for exon sequences and splice-site proximity in splice-site selection. Cell. 1986 Aug 29;46(5):681–690. doi: 10.1016/0092-8674(86)90343-0. [DOI] [PubMed] [Google Scholar]
  47. Roos D. X-CGDbase: a database of X-CGD-causing mutations. Immunol Today. 1996 Nov;17(11):517–521. doi: 10.1016/0167-5699(96)30060-1. [DOI] [PubMed] [Google Scholar]
  48. Roos D., de Boer M., Kuribayashi F., Meischl C., Weening R. S., Segal A. W., Ahlin A., Nemet K., Hossle J. P., Bernatowska-Matuszkiewicz E. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 1996 Mar 1;87(5):1663–1681. [PubMed] [Google Scholar]
  49. Royer-Pokora B., Kunkel L. M., Monaco A. P., Goff S. C., Newburger P. E., Baehner R. L., Cole F. S., Curnutte J. T., Orkin S. H. Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature. 1986 Jul 3;322(6074):32–38. doi: 10.1038/322032a0. [DOI] [PubMed] [Google Scholar]
  50. Schapiro B. L., Newburger P. E., Klempner M. S., Dinauer M. C. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med. 1991 Dec 19;325(25):1786–1790. doi: 10.1056/NEJM199112193252506. [DOI] [PubMed] [Google Scholar]
  51. Segal A. W., Cross A. R., Garcia R. C., Borregaard N., Valerius N. H., Soothill J. F., Jones O. T. Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. N Engl J Med. 1983 Feb 3;308(5):245–251. doi: 10.1056/NEJM198302033080503. [DOI] [PubMed] [Google Scholar]
  52. Segal A. W., West I., Wientjes F., Nugent J. H., Chavan A. J., Haley B., Garcia R. C., Rosen H., Scrace G. Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. Biochem J. 1992 Jun 15;284(Pt 3):781–788. doi: 10.1042/bj2840781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Skalnik D. G., Strauss E. C., Orkin S. H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem. 1991 Sep 5;266(25):16736–16744. [PubMed] [Google Scholar]
  54. Volpp B. D., Lin Y. In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease. J Clin Invest. 1993 Jan;91(1):201–207. doi: 10.1172/JCI116171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Volpp B. D., Nauseef W. M., Clark R. A. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science. 1988 Dec 2;242(4883):1295–1297. doi: 10.1126/science.2848318. [DOI] [PubMed] [Google Scholar]
  56. Wallach T. M., Segal A. W. Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro. Biochem J. 1997 Feb 1;321(Pt 3):583–585. doi: 10.1042/bj3210583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Woodman R. C., Newburger P. E., Anklesaria P., Erickson R. W., Rae J., Cohen M. S., Curnutte J. T. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells. Blood. 1995 Jan 1;85(1):231–241. [PubMed] [Google Scholar]
  58. Youssoufian H., Antonarakis S. E., Bell W., Griffin A. M., Kazazian H. H., Jr Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet. 1988 May;42(5):718–725. [PMC free article] [PubMed] [Google Scholar]
  59. Yu L., Zhen L., Dinauer M. C. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits. J Biol Chem. 1997 Oct 24;272(43):27288–27294. doi: 10.1074/jbc.272.43.27288. [DOI] [PubMed] [Google Scholar]
  60. de Boer M., Bolscher B. G., Dinauer M. C., Orkin S. H., Smith C. I., Ahlin A., Weening R. S., Roos D. Splice site mutations are a common cause of X-linked chronic granulomatous disease. Blood. 1992 Sep 15;80(6):1553–1558. [PubMed] [Google Scholar]
  61. de Saint-Basile G., Bohler M. C., Fischer A., Cartron J., Dufier J. L., Griscelli C., Orkin S. H. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype. Hum Genet. 1988 Sep;80(1):85–89. doi: 10.1007/BF00451463. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES